BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16343100)

  • 1. The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves' disease relapse.
    Ueda M; Inaba M; Kumeda Y; Nagasaki T; Hiura Y; Tahara H; Onoda N; Ishikawa T; Nishizawa Y
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):657-62. PubMed ID: 16343100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease.
    Nagasaki T; Inaba M; Fujiwara-Ueda M; Nishio J; Kumeda Y; Hiura Y; Tahara H; Ishimura E; Ishiko O; Nishizawa Y
    Biomed Pharmacother; 2010 Feb; 64(2):113-7. PubMed ID: 20006462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
    Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
    Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
    Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
    Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diagnostic Utility of Color Doppler Ultrasonography, Tc-99m Pertechnetate Uptake, and TSH-Receptor Antibody for Differential Diagnosis of Graves' Disease and Silent Thyroiditis: A Comparative Study.
    Zuhur SS; Ozel A; Kuzu I; Erol RS; Ozcan ND; Basat O; Yenici FU; Altuntas Y
    Endocr Pract; 2014 Apr; 20(4):310-9. PubMed ID: 24246346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis: elucidating diagnostic thresholds of peak systolic flow velocities in thyroid arteries for the discrimination of Graves' disease and destructive thyrotoxicosis.
    Li S; Ding Z; Li X; Fu M; Sang L; Yang M; Tang R; Gu T; Sang L
    Front Endocrinol (Lausanne); 2024; 15():1393126. PubMed ID: 38911037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
    Ide A; Amino N; Kang S; Yoshioka W; Kudo T; Nishihara E; Ito M; Nakamura H; Miyauchi A
    Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of thyrotoxic autoimmune thyroiditis patients with triplex Doppler ultrasonography.
    Karakas O; Karakas E; Cullu N; Demir Y; Kucukyavas Y; Surucu E; Yener S; Igci E
    Clin Imaging; 2014; 38(1):1-5. PubMed ID: 24119678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence?
    Zingrillo M; D'Aloiso L; Ghiggi MR; Di Cerbo A; Chiodini I; Torlontano M; Liuzzi A
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):201-6. PubMed ID: 8881453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of colour Doppler sonography in patients with Graves' disease.
    Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Rayudu BR; Modi KD
    West Indian Med J; 2009 Dec; 58(6):566-70. PubMed ID: 20583684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between peak systolic velocity of the inferior thyroid artery and technetium-99m pertechnetate thyroid uptake in differentiating Graves' disease from thyroiditis.
    Malik SA; Choh NA; Misgar RA; Khan SH; Shah ZA; Rather TA; Shehjar F; Laway BA
    Arch Endocrinol Metab; 2019; 63(5):495-500. PubMed ID: 31482952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum level of IL-7 in patients with active Graves' disease.
    Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
    Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
    Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mean peak systolic velocity of the superior thyroid artery is correlated with radioactive iodine uptake in untreated thyrotoxicosis.
    Chen L; Zhao X; Liu H; Wang Y; Li L; Lu B; Li Y; Hu R
    J Int Med Res; 2012; 40(2):640-7. PubMed ID: 22613425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathy.
    Kurioka Y; Inaba M; Kawagishi T; Emoto M; Kumeda Y; Inoue Y; Morii H; Nishizawa Y
    Eur J Endocrinol; 2001 Feb; 144(2):99-107. PubMed ID: 11182745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peak systolic velocity of superior thyroid artery for the differential diagnosis of thyrotoxicosis.
    Zhao X; Chen L; Li L; Wang Y; Wang Y; Zhou L; Zeng F; Li Y; Hu R; Liu H
    PLoS One; 2012; 7(11):e50051. PubMed ID: 23166817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study.
    Zuhur SS; Ozel A; Velet S; Buğdacı MS; Cil E; Altuntas Y
    Clinics (Sao Paulo); 2012; 67(2):125-9. PubMed ID: 22358236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.